Safety and Effectiveness of Empagliflozin/Linagliptin FDC in Uncontrolled T2DM Patients with COVID-19 Infection

被引：0
|
作者：
Sengupta, Asoktaru
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-1812-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1812-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel
    Manoj Chawla
    Sunil M. Jain
    Jothydev Kesavadev
    Brij M. Makkar
    Vijay Viswanathan
    Mangesh Tiwaskar
    Aravind R. Sosale
    Vijay Negalur
    Kirtikumar D. Modi
    Mukulesh Gupta
    Surinder Kumar
    Santosh Ramakrishnan
    Nilakshi Deka
    Nirmalya Roy
    Diabetes Therapy, 2021, 12 : 133 - 142
  • [42] Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naive Patients with Type 2 Diabetes (T2DM)
    Roden, Michael
    Weng, Jianping
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2014, 63 : A69 - A69
  • [43] Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel
    Chawla, Manoj
    Jain, Sunil M.
    Kesavadev, Jothydev
    Makkar, Brij M.
    Viswanathan, Vijay
    Tiwaskar, Mangesh
    Sosale, Aravind R.
    Negalur, Vijay
    Modi, Kirtikumar D.
    Gupta, Mukulesh
    Kumar, Surinder
    Ramakrishnan, Santosh
    Deka, Nilakshi
    Roy, Nirmalya
    DIABETES THERAPY, 2021, 12 (01) : 133 - 142
  • [44] Different Appearance of Chest CT Images of T2DM and NDM Patients with COVID-19 Pneumonia Based on an Artificial Intelligent Quantitative Method
    Lu, Shan
    Xing, Zhiheng
    Zhao, Shiyu
    Meng, Xianglu
    Yang, Juhong
    Ding, Wenlong
    Wang, Jigang
    Huang, Chencui
    Xu, Jingxu
    Chang, Baocheng
    Shen, Jun
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021
  • [45] Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naive Patients with Type 2 Diabetes (T2DM)
    Roden, Michael W.
    Weng, Jianping
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [46] Effectiveness and Safety of COVID-19 Vaccination in Patients with Malignant Disease
    Zhao, Li
    Fu, Lin
    He, Yuqin
    Li, Han
    Song, Yixuan
    Liu, Shaoyan
    VACCINES, 2023, 11 (02)
  • [47] Clinical Effectiveness and Safety of Remdesivir in Hemodialysis Patients with COVID-19
    Lim, Jeong-Hoo
    Park, Sang Don
    Jeon, Yena
    Chung, Yu Kyung
    Kwon, Jae Wan
    Jeon, You Hyun
    Jung, Hee-Yeon
    Park, Sun-Hee
    Kim, Chan-Duck
    Kim, Yong-Lim
    Kwon, Ki Tae
    Choi, Ji-Young
    Cho, Jang-Hee
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (11): : 2522 - 2525
  • [48] EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19
    Balykova, L. A.
    Zaslavskaya, K. Ya.
    Pavelkina, V. F.
    Pyataev, N. A.
    Selezneva, N. M.
    Kirichenko, N. V.
    Ivanova, A. Yu.
    Rodoman, G. V.
    Kolontarev, K. B.
    Skrupsky, K. S.
    Simakina, E. N.
    Mubarakshina, O. A.
    Taganov, A. V.
    Pushkar, D. Yu.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2022, 10 (01): : 113 - 126
  • [49] Editorial: Safety and Effectiveness of COVID-19 Vaccines on COVID-19 Infection and Its Long-Term Consequences
    Junqueira-Kipnis, Ana Paula
    VACCINES, 2025, 13 (02)
  • [50] Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
    Abdelgani, Siham
    Khattab, Ahmed
    Adams, John
    Abu-Farha, Mohamed
    Daniele, Guisepe
    Al-Mulla, Fahd
    Del Prato, Stefano
    DeFronzo, Ralph A.
    Abdul-Ghani, Muhammad
    DIABETES CARE, 2023, 46 (05) : 978 - 984
12345